Baudax Bio Inc logo

Baudax Bio Inc

3
OTCPK:BXRXQ (USA)   Ordinary Shares
$ 0.01 +0.0006 (+5.66%) 10:08 PM EST
At Loss
Market Cap:
$ 488.00K
Enterprise V:
$ 8.20M
Volume:
24.65K
Avg Vol (2M):
115.82K
Volume:
24.65K
At Loss
Avg Vol (2M):
115.82K

Business Description

Baudax Bio Inc logo
Baudax Bio Inc
NAICS : 325412 SIC : 2834
ISIN : US07160F4046

Share Class Description:

BXRXQ: Ordinary Shares
Description
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset -0.5
Debt-to-Equity -0.79
Debt-to-EBITDA -0.25
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -23.26
Distress
Grey
Safe
Beneish M-Score 6.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.1
9-Day RSI 41.13
14-Day RSI 41.72
6-1 Month Momentum % -93.35
12-1 Month Momentum % -99.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.07
Quick Ratio 0.07
Cash Ratio 0.02
Days Inventory 205.89
Days Sales Outstanding 121.19
Days Payable 317.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -524.1
Shareholder Yield % -1557.15

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -353.19
Operating Margin % -2759.89
Net Margin % -563.75
FCF Margin % -1127.34
ROA % -46.75
ROIC % -162.63
ROC (Joel Greenblatt) % -1151.16

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.01
EV-to-EBIT -0.23
EV-to-EBITDA -0.25
EV-to-Revenue 6.46
EV-to-Forward-Revenue 0.29
EV-to-FCF -0.57
Earnings Yield (Greenblatt) % -434.78
FCF Yield % -2931.56

Financials (Next Earnings Date:2024-05-10 Est.)

BXRXQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BXRXQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Baudax Bio Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.269
EPS (TTM) ($) -9.23
Beta 0.81
Volatility % 177.63
14-Day RSI 41.72
14-Day ATR ($) 0.004017
20-Day SMA ($) 0.013135
12-1 Month Momentum % -99.41
52-Week Range ($) 0.0103 - 3.4699
Shares Outstanding (Mil) 43.59

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Baudax Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Baudax Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Baudax Bio Inc Frequently Asked Questions

What is Baudax Bio Inc(BXRXQ)'s stock price today?
The current price of BXRXQ is $0.01. The 52 week high of BXRXQ is $3.47 and 52 week low is $0.01.
When is next earnings date of Baudax Bio Inc(BXRXQ)?
The next earnings date of Baudax Bio Inc(BXRXQ) is 2024-05-10 Est..
Does Baudax Bio Inc(BXRXQ) pay dividends? If so, how much?
Baudax Bio Inc(BXRXQ) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1